>Marché européen des dispositifs de test de crachat du cancer, par type de produit (kits de collecte de salive, dispositifs spécifiques aux fluides, écouvillon buccal, étiquettes à code-barres, boîte de cryoconservation de salive et autres), site de collecte (glande sous-mandibulaire/sous-linguale, glande parotide et glande salivaire mineure), application (cancer du foie et du poumon, cancer du sein, cancer du côlon et du rectum, cancer de la prostate, cancer du pancréas, cancer de la bouche, cancer de la thyroïde, cancer de l'endomètre, cancer du rein, leucémie, mélanome, lymphome non hodgkinien et autres), groupe d'âge (adulte et pédiatrie), méthode de collecte (bave passive, écouvillon buccal et autres), utilisateur final (hôpitaux, laboratoires de diagnostic, cliniques spécialisées en oncologie, instituts de recherche sur le cancer et autres), canal de distribution (appels d'offres directs, ventes au détail et autres) Pays (Allemagne, Royaume-Uni, France, Italie, Espagne, Russie, Pays-Bas, Suisse, Turquie, Autriche, Suède, Belgique, Estonie et reste de l'Europe) Tendances et prévisions de l'industrie jusqu'en 2028.
Analyse et perspectives du marché : marché européen des dispositifs de dépistage du cancer par crachat
Le marché européen des dispositifs de test de crachat du cancer devrait connaître une croissance significative au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché européen des dispositifs de test de crachat du cancer croît avec un TCAC de 9,3 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 224,29 millions USD d'ici 2028 contre 115,22 millions USD en 2020. La prévalence croissante des maladies chroniques et le nombre croissant de patients atteints de cancer sont les principaux moteurs qui devraient propulser la croissance du marché au cours de la période de prévision.
Le test salivaire est aujourd'hui largement utilisé pour détecter le cancer. Un test salivaire du cancer permet de détecter la présence ou l'absence d' ADN et d'ARN extracellulaires mutés . Les cellules tumorales libèrent de l'ADN et de l'ARN dans la circulation et ils pénètrent dans la salive. Les mutations sont détectables avec une grande précision dans la salive.
Le marché des dispositifs de test salivaire du cancer comprend des kits de test, des écouvillons, des cassettes et des dispositifs utilisés pour la détection de médicaments, d'infections ou de maladies chez l'homme. Plusieurs types de kits utilisent différents types de méthodes de biologie moléculaire pour la détection des maladies. ELISA, PCR, immuno-essai et dosages enzymatiques, entre autres, sont des techniques moléculaires utilisées pour les tests salivaires.
Le rapport sur le marché européen des dispositifs de test de dépistage du cancer fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché européen des dispositifs de dépistage du cancer par crachat
The Europe cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Europe cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to increasing pool of cancer patients in the region.
- On the basis of site of collection, the Europe cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to increasing healthcare expenditure and growing awareness among people about cancer.
- On the basis of application, the Europe cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market owing to excessive smoking among people and rising prevalence of liver cirrhosis.
- On the basis of age group, the Europe cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to surging pool of geriatric population and increasing prevalence chronic diseases in the region.
- On the basis of method of collection, the Europe cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market owing to its non-invasive method with better patient compliance.
- On the basis of end user, the Europe cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market owing to surging volume of cancer patients and better treatment options for different types of cancer.
- On the basis of distribution channel, the Europe cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to growing presence of major players in the market.
Europe Cancer Spit Test Devices Market Country Level Analysis
The Europe cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.
Countries covered in the Europe cancer spit test device market report are Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Sweden, Belgium, Estonia, and Rest of Europe. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to increasing technological advancements in the region. Germany is dominating the European market owing to growing presence of key players in the market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the Europe cancer spit test devices market
Germany is leading the growth of Europe region and saliva collection kits segment is dominating the country due to rising demand for POCT devices.
Europe cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the Europe cancer spit test device market sales, impact of advancement in the Europe cancer spit test device market and changes in regulatory scenarios with their support for the Europe cancer spit test devices market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Europe Cancer Spit Test Device Market Share Analysis
Europe cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe cancer spit test devices market.
Les principaux acteurs couverts par le rapport sont DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG, Miraclean Technology Co., Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation et Canvax (une filiale de dobuss) parmi d'autres acteurs nationaux et européens. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux lancements de produits et accords sont également initiés par les entreprises du monde entier, ce qui accélère encore la croissance du marché européen des dispositifs de test de dépistage du cancer par crachats.
Par exemple,
- En février 2021, Thermo Fisher Scientific a reçu six CMO Leadership Awards. L'entreprise a remporté les six catégories, notamment les capacités, la compatibilité, l'expertise, la qualité, la fiabilité et le service. C'est la deuxième année consécutive que Thermo Fisher reçoit cette reconnaissance dans les six catégories et la huitième fois au total que l'entreprise est honorée par les CMO Leadership Awards. Cela a renforcé la crédibilité de l'entreprise et a contribué à la génération de revenus.
- En janvier 2021, DNA Genotek a annoncé que la Food and Drug Administration (FDA) des États-Unis avait accordé une autorisation d'utilisation générale 510(k) pour sa gamme de produits OrageneDx. Cette approbation de la FDA a renforcé la crédibilité de l'entreprise sur le marché et a fait augmenter la demande pour ce produit.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE CANCER SPIT TEST DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORKS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN CANCER BURDEN WORLDWIDE
6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS
6.1.3 RISE IN GERIATRIC POPULATION
6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER
6.1.5 RISE IN EXPENDITURE ON HEALTHCARE
6.2 RESTRAINTS
6.2.1 INCREASE PREVALENCE OF COVID-19
6.2.2 LACK OF EARLY DETECTION
6.3 OPPORTUNITIES
6.3.1 RECOMMENDATIONS FOR CANCER SCREENING
6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING
6.3.3 RISE IN R&D ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT REGULATION POLICY
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS
7 IMPACT OF COVID-19 THE ON EUROPE CANCER SPIT TEST DEVICES MARKET
7.1 IMPACT ON SUPPLY CHAIN
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS FOR MANUFACTURERS
7.4 CONCLUSION
8 EUROPE CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SALIVA COLLECTION KIT
8.2.1 DNA EXTRACT
8.2.2 RNA EXTRACT
8.3 FLUID SPECIFIC DEVICES
8.4 ORAL SWAB
8.5 BAR-CODE LABELS
8.6 SALIVA CRYOSTORAGE BOX
8.7 OTHERS
9 EUROPE CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION
9.1 OVERVIEW
9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND
9.3 PAROTID GLAND
9.4 MINOR SALIVARY GLAND
10 EUROPE CANCER SPIT TEST DEVICE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 LIVER-LUNG CANCER
10.3 BREAST CANCER
10.4 COLON AND RECTAL CANCER
10.5 PROSTATE CANCER
10.6 PANCREATIC CANCER
10.7 ORAL CANCER
10.8 THYROID CANCER
10.9 ENDOMETRIAL CANCER
10.1 KIDNEY CANCER
10.11 LEUKEMIA
10.12 MELANOMA
10.13 NON-HODGKIN LYMPHOMA
10.14 OTHERS
11 EUROPE CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 EUROPE CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION
12.1 OVERVIEW
12.2 PASSIVE DROOL
12.3 ORAL SWAB
12.4 OTHERS
13 EUROPE CANCER SPIT TEST DEVICE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ONCOLOGY SPECIALITY CLINICS
13.5 CANCER RESEARCH INSTITUTES
13.6 OTHERS
14 EUROPE CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 OTHERS
15 EUROPE CANCER SPIT TEST DEVICES MARKET, BY REGION
15.1 EUROPE
15.1.1 GERMANY
15.1.2 FRANCE
15.1.3 U.K.
15.1.4 ITALY
15.1.5 SPAIN
15.1.6 BELGIUM
15.1.7 NETHERLANDS
15.1.8 SWITZERLAND
15.1.9 AUSTRIA
15.1.10 RUSSIA
15.1.11 SWEDEN
15.1.12 TURKEY
15.1.13 ESTONIA
15.1.14 REST OF EUROPE
16 EUROPE CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BIOCARTIS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BD
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 F. HOFFMANN-LA ROCHE LTD
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 QIAGEN
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AGILENT TECHNOLOGIES, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 BIOMÉRIEUX SA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANVAX
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COLOR HEALTH, INC.
18.9.1 1.6.1 COMPANY SNAPSHOT
18.9.2 1.6.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 DNA GENOTEK
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENT
18.11 ILLUMINA, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 MIRACLEAN TECHNOLOGY CO.,LTD.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 OASIS DIAGNOSTICS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 PERIRX
18.14.1 COMPANY SNAPSHOT
18.14.2.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SALIMETRICS, LLC
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SARSTEDT AG & CO. KG
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 THERMO FISHER SCIENTIFIC INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.
TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.
TABLE 3 EUROPE CANCER SPIT TEST DEVICE MARKET, By product Type, 2019-2028 (USD million)
TABLE 4 EUROPE saliva collection kit IN CANCER SPIT TEST DEVICE MARKET, By Region, 2019-2028 (USD Million)
TABLE 5 Europe Saliva Collection Kit in Cancer Spit Test Devices Market, By Product Type, 2019-2028 (USD Million)
TABLE 6 Europe Fluid Specific Devices in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 7 Europe Oral Swab in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 8 Europe Bar-Code Labels in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 9 Europe Saliva Cryostorage Box in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 10 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 11 EUROPE CANCER SPIT TEST DEVICE MARKET, By SITE OF COLLECTION, 2019-2028 (USD Million)
TABLE 12 Europe Sub-mandibular/Sub-lingual GLAND in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 13 Europe Parotid Gland in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 14 Europe Minor Salivary Gland in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 15 Europe Cancer Spit Test Devices Market, By Application, 2019-2028 (USD Million)
TABLE 16 Europe Liver-Lung Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 17 Europe Breast Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 18 Europe Colon and Rectal Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 19 Europe Prostate Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 20 Europe Pancreatic Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 21 Europe Oral Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 22 Europe Thyroid Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe Endometrial Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 24 Europe Kidney Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe Leukemia in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 26 Europe Melanoma in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe Non-Hodgkin Lymphoma in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 28 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 29 EUROPE CANCER SPIT TEST DEVICE MARKET, By AGE GROUP, 2019-2028 (USD million)
TABLE 30 Europe Adult in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 31 Europe Pediatrics in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 32 Europe Cancer Spit Test Devices Market, By Method of Collection, 2019-2028 (USD Million)
TABLE 33 Europe Passive Drool in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 34 Europe Oral Swab in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 35 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 36 Europe Cancer Spit Test Devices Market, By END USER, 2019-2028 (USD Million)
TABLE 37 Europe Hospitals in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)
TABLE 38 Europe Diagnostic Laboratories in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)
TABLE 39 Europe Oncology Speciality Clinics in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)
TABLE 40 Europe Cancer Research Institutes in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)
TABLE 41 Europe Others in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)
TABLE 42 Europe Cancer Spit Test Devices Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)
TABLE 43 Europe Direct Tender in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 44 Europe Retail Sales in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 45 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)
TABLE 46 EUROPE CANCER SPIT TEST DEVICES market, By Country, 2019-2028 (USD Million)
TABLE 47 EUROPE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 48 EUROPE Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 49 EUROPE CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 50 EUROPE CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 51 EUROPE CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 52 EUROPE CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 53 EUROPE CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 54 EUROPE CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 55 GERMANY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 56 GERMANY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 57 GERMANY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 58 GERMANY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 59 GERMANY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 60 GERMANY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 61 GERMANY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 62 GERMANY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 63 FRANCE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 64 FRANCE Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 65 FRANCE CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 66 FRANCE CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 67 FRANCE CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 68 FRANCE CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 69 FRANCE CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 70 FRANCE CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 71 U.K. CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 72 U.K. Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 73 U.K. CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 74 U.K. CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 75 U.K. CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 76 U.K. CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 77 U.K. CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 78 U.K. CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 79 ITALY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 80 ITALY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 81 ITALY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 82 ITALY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 83 ITALY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 84 ITALY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 85 ITALY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 86 ITALY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 87 SPAIN CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 88 SPAIN Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 89 SPAIN CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 90 SPAIN CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 91 SPAIN CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 92 SPAIN CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 93 SPAIN CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 94 SPAIN CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 95 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 96 BELGIUM Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 97 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 98 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 99 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 100 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 101 BELGIUM CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 102 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 103 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 104 NETHERLANDS Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 105 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 106 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 107 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 108 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 109 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 110 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 111 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 112 SWITZERLAND Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 113 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 114 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 115 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 116 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 117 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 118 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 119 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 120 AUSTRIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 121 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 122 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 123 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 124 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 125 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 126 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 127 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 128 RUSSIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 129 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 130 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 131 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 132 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 133 RUSSIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 134 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 135 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 136 SWEDEN Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 137 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 138 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 139 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 140 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 141 SWEDEN CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 142 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 143 TURKEY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 144 TURKEY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 145 TURKEY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 146 TURKEY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 147 TURKEY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 148 TURKEY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 149 TURKEY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 150 TURKEY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 151 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
TABLE 152 ESTONIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)
TABLE 153 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)
TABLE 154 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)
TABLE 155 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)
TABLE 156 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)
TABLE 157 ESTONIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)
TABLE 158 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 159 REST OF EUROPE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)
Liste des figures
LIST OF FIGURES
FIGURE 1 EUROPE CANCER SPIT TEST DEVICES MARKET : segmentation
FIGURE 2 EUROPE CANCER SPIT TEST DEVICES MARKET : data triangulation
FIGURE 3 EUROPE CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS
FIGURE 4 EUROPE CANCER SPIT TEST DEVICES MARKET: Europe vs REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 EUROPE CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE CANCER SPIT TEST DEVICES MARKET : vendor share analysis
FIGURE 10 EUROPE CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 11 THE increasing prevalence of chronic diseases and rising healthcare expenditure are expected to drive THE EUROPE CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 salvia Collection kit segment is expected to account for the largest share of the EUROPE CANCER SPIT TEST DEVICES MARKET in 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe cancer Spit Test Devices Market
FIGURE 14 Estimated number of new cases in 2018, worldwide, both sexes, all ages
FIGURE 15 Estimated age-standardized incidence rates (World) in 2018, worldwide, both sexes, all ages
FIGURE 16 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, 2020
FIGURE 17 EUROPE CANCER SPIT TEST DEVICE MARKET: By producT TYPE, 2021-2028 (USD million)
FIGURE 18 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, CAGR (2021-2028)
FIGURE 19 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, LIFELINE CURVE
FIGURE 20 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, 2020
FIGURE 21 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, 2021-2028 (USD million)
FIGURE 22 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, CAGR (2021-2028)
FIGURE 23 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, LIFELINE CURVE
FIGURE 24 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, 2020
FIGURE 25 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, 2021-2028 (USD million)
FIGURE 26 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, CAGR (2021-2028)
FIGURE 27 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, LIFELINE CURVE
FIGURE 28 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, 2020
FIGURE 29 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, 2021-2028 (USD million)
FIGURE 30 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, CAGR (2021-2028)
FIGURE 31 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, LIFELINE CURVE
FIGURE 32 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, 2020
FIGURE 33 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, 2021-2028 (USD million)
FIGURE 34 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, CAGR (2021-2028)
FIGURE 35 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, LIFELINE CURVE
FIGURE 36 Europe CANCER SPIT TEST DEVICE market: END USER, 2020
FIGURE 37 Europe CANCER SPIT TEST DEVICE market: END USER, 2021-2028 (USD million)
FIGURE 38 Europe CANCER SPIT TEST DEVICE market: END USER, CAGR (2021-2028)
FIGURE 39 Europe CANCER SPIT TEST DEVICE market: END USER, LIFELINE CURVE
FIGURE 40 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, 2020
FIGURE 41 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, 2021-2028 (USD million)
FIGURE 42 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 EUROPE CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)
FIGURE 45 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)
FIGURE 46 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 EUROPE CANCER SPIT TEST DEVICES MARKET: BY product TYPE (2021-2028)
FIGURE 49 EUROPE CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.